TransMedics Group Inc.

NASDAQ: TMDX · Real-Time Price · USD
127.45
-2.29 (-1.77%)
At close: Aug 15, 2025, 3:59 PM
127.03
-0.33%
After-hours: Aug 15, 2025, 07:53 PM EDT

TransMedics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
531.29M 488.23M 441.54M 401.09M 358.76M 296.92M 241.62M 191.82M 151.08M 119.13M 93.46M 71.75M 51.44M 39.09M 30.26M 28.22M 29.94M 25.16M
Cost of Revenue
213.62M 197.98M 179.66M 163.3M 141.15M 111.73M 87.53M 64.95M 46.75M 37.2M 28.19M 20.2M 14.23M 10.64M 9.1M 9.22M 9.68M 8.58M
Gross Profit
317.68M 290.25M 261.88M 237.79M 217.61M 185.19M 154.09M 126.87M 104.33M 81.93M 65.27M 51.55M 37.21M 28.45M 21.16M 19M 20.27M 16.59M
Operating Income
76.58M 52.52M 37.5M 31.45M -803K -14.22M -28.73M -38.11M -15.32M -24.16M -31.44M -35.99M -42.17M -42.29M -39.43M -34M -26.88M -24.87M
Interest Income
8.72M 9.62M 13.19M 15.04M 16.93M 15.97M 12.95M 9.27M 4.47M 2.04M 1.49M 400K n/a 171K 171K 737K 1.24M 1.44M
Pretax Income
74.09M 50.06M 35.78M 32.65M 1.48M -11.65M -26.67M -37.23M -17.71M -28.23M -36.16M -42.12M -47.66M -46.82M -44.18M -37.83M -29.96M -27.79M
Net Income
71.66M 48.95M 35.46M 32.64M 3M -10.2M -25.03M -35.78M -17.78M -28.3M -36.23M -42.18M -47.72M -46.86M -44.22M -37.86M -29.98M -27.81M
Selling & General & Admin
177.27M 175.98M 168.42M 156.07M 144.07M 130.63M 119.55M 106.72M 92.92M 80.94M 69.9M 60.17M 53.66M 45.44M 38.28M 32.46M 27.62M 24.32M
Research & Development
63.82M 61.75M 55.97M 50.27M 74.34M 68.78M 63.27M 58.26M 26.73M 25.15M 26.81M 27.37M 25.73M 25.31M 22.3M 20.54M 19.53M 17.14M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
241.1M 237.73M 224.38M 206.34M 218.41M 199.41M 182.82M 164.98M 119.64M 106.09M 96.71M 87.54M 79.38M 70.74M 60.59M 53M 47.15M 41.46M
Interest Expense
14.13M 14.27M 14.41M 14.44M 14.42M 13.3M 10.79M 8.19M 5.39M 3.76M 3.63M 3.6M 3.79M 3.88M 3.87M 3.87M 3.86M 3.9M
Selling & Marketing Expenses
n/a -100K -200K -200K -200K 1.32M 1.42M 19.63M 19.63M 19.4M 19.4M 1.19M 1.19M n/a n/a n/a n/a n/a
Cost & Expenses
454.71M 435.71M 404.04M 369.63M 359.56M 311.14M 270.35M 229.93M 166.4M 143.29M 124.9M 107.74M 93.61M 81.38M 69.69M 62.22M 56.82M 50.04M
Income Tax Expense
2.43M 1.11M 316K 16K -1.52M -1.46M -1.64M -1.46M 70K 71K 66K 64K 54K 38K 36K 29K 26K 26K
Shares Outstanding (Basic)
33.91M 33.72M 33.59M 33.44M 33.12M 32.76M 32.64M 32.61M 32.55M 32.26M 32.01M 30.23M 27.98M 27.79M 27.77M 27.7M 27.62M 27.37M
Shares Outstanding (Diluted)
40.56M 39.91M 35.21M 35.68M 35.29M 34.68M 34.18M 32.61M 32.55M 32.26M 32.01M 30.23M 27.98M 27.95M 27.77M 27.7M 27.62M 27.37M
EPS (Basic)
2.12 1.46 1.07 0.99 0.08 -0.32 -0.77 -1.1 -0.57 -0.95 -1.25 -1.5 -1.72 -1.7 -1.61 -1.38 -1.1 -1.07
EPS (Diluted)
1.93 1.36 1.01 0.94 0.04 -0.34 -0.77 -1.1 -0.57 -0.95 -1.25 -1.5 -1.72 -1.7 -1.61 -1.38 -1.1 -1.07
EBITDA
111.94M 82.66M 63.21M 58.14M 23.66M 9.7M -7.18M -22.58M -6.68M -19.57M -28.43M -34.58M -40.55M -40.05M -37.66M -32.18M -24.37M -22.24M
EBIT
84.28M 57.13M 39.41M 36.32M 9.06M -1.93M -15.88M -29.04M -12.32M -24.38M -32.44M -38.42M -43.77M -42.94M -40.3M -33.96M -26.1M -23.89M
Depreciation & Amortization
27.66M 25.53M 23.8M 21.82M 14.6M 11.62M 8.7M 6.46M 5.64M 4.99M 4.2M 4.02M 3.4M 2.89M 2.65M 1.78M 1.73M 1.65M